alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This  schedule  contains  summary  financial  information  extracted from the
Company's  consolidated  balance  sheet  at December 31, 1997 and Consolidated
Statement  of  Operations  for  the six months ended December 31, 1997, and is
qualified  in  its  entirety  by  reference  to  such  financial  statements.
</LEGEND>
<MULTIPLIER>   1000
       
<S>                                     <C>

<PERIOD-TYPE>                           6-MOS
<FISCAL-YEAR-END>                       JUN-30-1997
<PERIOD-START>                          JUL-01-1997
<PERIOD-END>                            DEC-31-1997
<CASH>                                           0 
<SECURITIES>                                     0 
<RECEIVABLES>                                20394 
<ALLOWANCES>                                   729 
<INVENTORY>                                   7262 
<CURRENT-ASSETS>                             33624 
<PP&E>                                       35403 
<DEPRECIATION>                               22371 
<TOTAL-ASSETS>                               48033 
<CURRENT-LIABILITIES>                        23230 
<BONDS>                                        434 
<COMMON>                                       472 
<PREFERRED-MANDATORY>                            0 
<PREFERRED>                                      0 
<OTHER-SE>                                   22323 
<TOTAL-LIABILITY-AND-EQUITY>                 48033 
<SALES>                                      18625 
<TOTAL-REVENUES>                             41621 
<CGS>                                         8793 
<TOTAL-COSTS>                                20975 
<OTHER-EXPENSES>                                 0 
<LOSS-PROVISION>                                 0 
<INTEREST-EXPENSE>                             450 
<INCOME-PRETAX>                               3631 
<INCOME-TAX>                                   908 
<INCOME-CONTINUING>                           2723 
<DISCONTINUED>                                   0 
<EXTRAORDINARY>                                  0 
<CHANGES>                                        0 
<NET-INCOME>                                  2723 
<EPS-PRIMARY>                                  .06 
<EPS-DILUTED>                                  .06 
        

</TABLE>
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

 WASHINGTON, D.C. 20460 

 OFFICE OF 

 CHEMICAL SAFETY AND 

 POLLUTION PREVENTION 

CERTIFIED MAIL

June 16, 2011 

Mr. William Marhlburg 

Nufarm Americas, Inc. 

150 Harvester Drive, Suite 200 

Burr Ridge IL 60527 

Re: Additional Information Required for Previously Submitted Amitrole Environmental Fate 

Studies; EPA Grants Waiver of Post-Application Dermal Exposure Study Required by the 

Amitrole RED DCI 

Dear Mr. Marhlburg: 

 As you may be aware, the Environmental Protection Agency (EPA or the Agency) has 

recently started the registration review process for the active ingredient amitrole, for which 

Nufarm Americas, Inc. (Nufarm) is the technical registrant. The docket opening, announcing the 

availability of amitrole related registration review documents and a 60-day public comment 

period, is scheduled for June 29, 2011. During the development of the amitrole registration 

review documents, several issues came to light which require follow-up action from Nufarm and 

EPA. First, EPA is requiring additional information on several previously submitted 

environmental fate studies; and second, EPA has waived a data requirement from the 

Reregistration Eligibility Decision (RED) data call-in (DCI). Further details regarding these two 

matters are provided below: 

(1) Additional information is required for several previously submitted environmental 

fate studies. This information is needed in order to conduct a full review of the submitted data. 

Please submit responses to these questions as soon as possible but no later than one month after 

receipt of this letter. Responses to the questions below along with the Agency’s review for 

acceptability of the submitted data will determine whether these guideline requirements will be 

called-in under registration review. 

• For the aerobic soil metabolism study (MRIDs 434557801 and 44687901), the soil used 

in the experiment was from Scotland. What U.S. soil is represented by the soil used in 

the study? If the soil used has no U.S. equivalent, then a new study will be required. 

• For the aerobic aquatic metabolism study (MRIDs 43099801 and 44687902), the water 

and sediment used in the experiment were from Scotland. What U.S. soil or sediment is 

represented by the sediment used in the study? If the soil or sediment used has no U.S. 

equivalent, a new study will be required.
www.group3aviation.com 16425 Hart Street

Van Nuys, CA 91406

United States

PHONE 818 994 9376 FAX 818 994 9384 EMAIL: group3 @group3aviation.com

Federal Aviation Administration

Office of Aerospace Medicine

Attention: Kevin Kearns, AAM

- 850

15000 Aviation Bl vd., Room 5012

Lawndale, CA 90261

November 11, 2011

Dear Inspector Kearns,

Group 3 Aviation would like to petition the Federal Aviation Administration for exemption from 14 CFR

P art 120. Group 3 Aviation requests an exemption from having to maintain tw o separate Anti

- Drug and

Alcohol programs.

Currently Group 3 Aviation maintains Anti

- Drug and Alcohol programs for two separate operations

 Part 135 On

- Demand Air Charter

 Part 91.147 Passenger Carrying Scenic Flight Tour Operations.

At this time we have pilots and a Maintenance Director that are enrolled in each program. The

redundancy of testing is costly to us as a small business, both in testing fees and monthly maintenance

costs through our consortium.

We believe that having one program for all pilots and our maintenance director will streamline operations

for our Anti

- drug and Alcohol program managers making the management and implementation more

efficient.

The benefit to our company will come in the form of decreased costs and more efficient use of employee

time. Public safety shall not be compromised; the program will not change as all safety sensitive

employees will continue to be enrolled and subject to the same program rules as they currently are.

B enefit s to public will be to eliminate redundancy therefore decreasing cos ts to the American taxpayer, by

utilizing the same FAA Anti

- Drug and Alcohol Abatement teams on a single visit annually

.

If you require further details please contact me at 818

- 994

- 9 376.

Regards,

Claudia Herrera

President
Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 08-10564

Conference Calendar

UNITED STATES OF AMERICA

Plaintiff-Appellee

v.

ANTONIO ZAVALA-RAMIREZ

Defendant-Appellant

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 4:07-CR-186-1

Before JONES, Chief Judge, and JOLLY and ELROD, Circuit Judges.

PER CURIAM:*

The Federal Public Defender appointed to represent Antonio ZavalaRamirez has moved for leave to withdraw and has filed a brief in accordance

with Anders v. California, 386 U.S. 738 (1967). Zavala-Ramirez has not filed a

response. Our independent review of the record and counsel’s brief discloses no

nonfrivolous issue for appeal. Accordingly, counsel’s motion for leave to

withdraw is GRANTED, counsel is excused from further responsibilities herein,

and the APPEAL IS DISMISSED. See 5TH CIR. R. 42.2.

United States Court of Appeals

Fifth Circuit

F I L E D

April 30, 2009

Charles R. Fulbruge III

Clerk
# Official Journal L 49/2021

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 49 |
| | |
| English edition | Legislation | Volume 6412 February 2021 |

ISSN 1977-0677

Official Journal

of the European Union

L 49

English edition

Legislation

Volume 6412 February 2021

---

| Contents | | I   Legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Regulation (EU) 2021/167 of the European Parliament and of the Council of 10 February 2021 amending Regulation (EU) No 654/2014 concerning the exercise of the Union’s rights for the application and enforcement of international trade rules | 1 |
| | * | Regulation (EU) 2021/168 of the European Parliament and of the Council of 10 February 2021 amending Regulation (EU) 2016/1011 as regards the exemption of certain third-country spot foreign exchange benchmarks and the designation of replacements for certain benchmarks in cessation, and amending Regulation (EU) No 648/2012 (
  1
  ) | 6 |

Contents

I   Legislative acts

page

REGULATIONS

*

Regulation (EU) 2021/167 of the European Parliament and of the Council of 10 February 2021 amending Regulation (EU) No 654/2014 concerning the exercise of the Union’s rights for the application and enforcement of international trade rules

1

*

Regulation (EU) 2021/168 of the European Parliament and of the Council of 10 February 2021 amending Regulation (EU) 2016/1011 as regards the exemption of certain third-country spot foreign exchange benchmarks and the designation of replacements for certain benchmarks in cessation, and amending Regulation (EU) No 648/2012 (
  1
  )

1

6

| | | II   Non-legislative acts |
| --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Implementing Regulation (EU) 2021/169 of 11 February 2021 amending Annex I to Regulation (EC) No 798/2008 as regards the entry for the United Kingdom in the list of third countries, territories, zones or compartments from which certain poultry commodities may be imported into and transit through the Union in relation to highly pathogenic avian influenza (
  1
  ) | 18 |

II   Non-legislative acts

REGULATIONS

*

Commission Implementing Regulation (EU) 2021/169 of 11 February 2021 amending Annex I to Regulation (EC) No 798/2008 as regards the entry for the United Kingdom in the list of third countries, territories, zones or compartments from which certain poultry commodities may be imported into and transit through the Union in relation to highly pathogenic avian influenza (
  1
  )

1

18

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
[Federal Register Volume 74, Number 59 (Monday, March 30, 2009)]
[Notices]
[Page 14181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7038]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6561]


Culturally Significant Objects Imported for Exhibition 
Determinations: ``Wine, Worship and Sacrifice: The Golden Graves of 
Ancient Vani''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, Delegation of Authority No. 236 
of October 19, 1999, as amended, and Delegation of Authority No. 257 of 
April 15, 2003 [68 FR 19875], I hereby determine that the objects to be 
included in the exhibition ``Wine, Worship and Sacrifice: The Golden 
Graves of Ancient Vani,'' imported from abroad for temporary exhibition 
within the United States, are of cultural significance. The objects are 
imported pursuant to loan agreements with the foreign owner or 
custodian. The objects were originally exhibited in the United States 
in 2007 and 2008, went on to an international tour, and are now 
returning. I also determine that the exhibition or display of the 
exhibit objects at the Getty Villa, Los Angeles, CA, from on or about 
July 16, 2009, until on or about October 5, 2009, and at possible 
additional exhibitions or venues yet to be determined, is in the 
national interest. Public Notice of these Determinations is ordered to 
be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Carol B. Epstein, Attorney-
Adviser, Office of the Legal Adviser, U.S. Department of State 
(telephone: 202/453-8048). The address is U.S. Department of State, SA-
44, 301 4th Street, SW., Room 700, Washington, DC 20547-0001.

    Dated: March 20, 2009.
C. Miller Crouch,
Acting Assistant Secretary for Educational and Cultural Affairs, 
Department of State.
 [FR Doc. E9-7038 Filed 3-27-09; 8:45 am]
BILLING CODE 4710-05-P
Michael PRANCE, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-1327

District Court of Appeal of Florida, Second District.

May 31, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                           <C>
<PERIOD-TYPE>                 9-MOS
<FISCAL-YEAR-END>             DEC-30-1995
<PERIOD-END>                  SEP-30-1995
<CASH>                        1,885
<SECURITIES>                  0
<RECEIVABLES>                 0
<ALLOWANCES>                  0
<INVENTORY>                   0
<CURRENT-ASSETS>              1,885
<PP&E>                        0
<DEPRECIATION>                0
<TOTAL-ASSETS>                1,885
<CURRENT-LIABILITIES>         176,564
<BONDS>                       0
<PREFERRED-MANDATORY>         0
<PREFERRED>                   0
<COMMON>                      17,310
<OTHER-SE>                    (191,989)
<TOTAL-LIABILITY-AND-EQUITY>  1,885
<SALES>                       0
<TOTAL-REVENUES>              10,800
<CGS>                         0
<TOTAL-COSTS>                 0
<OTHER-EXPENSES>              186,100
<LOSS-PROVISION>              0
<INTEREST-EXPENSE>            0
<INCOME-PRETAX>               (175,300)
<INCOME-TAX>                  0
<INCOME-CONTINUING>           (175,300)
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  (175,300)
<EPS-PRIMARY>                 (.101)
<EPS-DILUTED>                 0
        


</TABLE>
##### 



EXHIBIT 32.2 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Winland Electronics, Inc. (the
Company) on Form 10-QSB for the quarter ended June 30, 2004 as filed with the
Securities and Exchange Commission (the Report), I, Jennifer A. Thompson,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350,
as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company. Dated: August 16, 2004 /s/ Jennifer A. ThompsonJennifer A. ThompsonChief Financial Officer
Exhibit 32.1  EXHIBIT 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Annual Report of BRAZIL GOLD CORP. (the "Company") on Form 10-K for the period ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Conrad R. Huss, Chief Executive Officer, Secretary and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   Date:  March 21, 2013  By: /s/Conrad R. Huss Name: Conrad R. Huss Title: Director, Chief Executive Officer, Secretary, Chief Financial Officer
Exhibit 32.1





Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In  connection with the amended Annual Report of On4 Communications, Inc. (the “Company”) on Form 10-K/A for the period ended October 31, 2009, as filed with the Securities and Exchange Commission (the “Report”), I, Cameron Robb, the Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:      September 29, 2010





By:        /s/ Cameron Robb


Cameron Robb


President and Chief Executive Officer
[Federal Register Volume 74, Number 68 (Friday, April 10, 2009)]
[Notices]
[Page 16408]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8110]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel.
    Date: May 5, 2009.
    Time: 2 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Democracy II, 6707 
Democracy Blvd., 920, MSC-5469, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Ruth Grossman, DDS, Scientific Review Officer, 
National Institutes of Biomedical Imaging, and Bioengineering, 6707 
Democracy Boulevard, Room 960, Bethesda, MD 20892, 301-496-8775, 
<a href="/cdn-cgi/l/email-protection#3d5a4f524e4e505c534f4e7d505c545113535455135a524b"><span class="__cf_email__" data-cfemail="f89f8a978b8b9599968a8bb895999194d6969190d69f978e">[email protected]</span></a>.

    Dated: April, 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-8110 Filed 4-9-09; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Comments to EPA Hearing on PVC MACT Proposed Rule 

Beverly Smiley, Executive Director, 

Solutions Through Science 

My name is Beverly Smiley. I am a native and lifelong resident of Baton 

Rouge, Louisiana. I grew up in the industrial area of North Baton Rouge. 

My father, as well as the fathers of most of my childhood friends, worked at 

the plants during that time. 

I have chosen to remain in Baton Rouge, having been educated here and 

raising my two children here. During the years I have lived in this 

community, within just a few miles of the industrial plants, I have always felt 

safe. I have worked in this area my adult life, first for Girl Scouts and then 

for the Food Bank, which was, located right across the street from the 

plants, and later I chose to work for the chlorine and vinyl industry. I feel as 

safe when I am on site at one of my member facilities as I have anywhere 

else I have worked. 

The chlor-vinyl industry established facilities in Louisiana because of our 

natural resources needed to manufacture chlorine and vinyl; salt domes 

which are located throughout South Louisiana, natural gas, and water 

ways. Salt is the most plentiful material on earth and PVC, by weight, is 57 

per cent salt. Natural gas is plentiful and affordable in Louisiana and is a 

clean burning energy source. Water, which is used in our manufacturing 

process, is then returned purer than its original state and runoff from rain is 

purified before it is released into the environment. 

These companies provided good, steady jobs when I was growing up, just 

as they do now. They are an important part of the community providing 

economic benefits for our city and state. 

Many of the things we need and use every day are manufactured from the 

products that are made in the facilities that produce PVC resins in 

Louisiana. The products include a large per cent of our building materials 

such as double pane vinyl windows that are energy efficient and that never 

need painting; vinyl siding that is durable and that is not susceptible to 

termites; PVC pipe that conduct safe drinking water into our homes and 

public buildings; and insulation for electric wiring and computer cables. 

Vinyl also offers safe, affordable materials for IV and blood bags, tubing, 

and medical supplies such as surgical gloves, inflatable splints, and vinyl is 
compatible with virtually all pharmaceutical products used in healthcare 

settings. Because of its purity, PVC offers a safe material that our 

healthcare professionals can depend on in their work. 

The companies that manufacture vinyl are operated in a safe and 

environmental sound manner and spend thousands of hours training their 

employees in safety and environmental management. 

Because of improved technology and regulations emissions have 

decreased steadily over the years and will continue to do so.
|                             | Winland      Electronics, Inc. |                                            |
|----------------------------------|--------------------------------|-------------------------------------------------|
|                             |                           |                                            |   |
| Date:       August 12, 2008 | By:                            | /s/ Thomas      J. de Petra                |   |
|                             |                           | Thomas      J. de Petra     |   |
|                             |                           | President      and Chief Executive Officer      |   |
|                             |                           |                                            |   |